Adjuvance Technologies Inc.
Biotechnology company · Lincoln, Nebraska, United States
Adjuvance Technologies Inc. is a biotechnology company headquartered in Lincoln, Nebraska, United States. It has received 5 US government small-business research awards (SBIR/STTR) from health agencies, $3.9 million in total, most recently in 2020. It has reported private securities offerings to the US SEC, most recently $11 million sold in a notice filed in 2019.
Adjuvance Technologies at a glance
What does Adjuvance Technologies do?
US government research funding
5 SBIR/STTR small-business research awards from US health agencies, $3.9 million in total (2014 to 2020). NIH funding came from the National Institute of Allergy and Infectious Diseases.
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $10.7 million sold (2019).
Frequently asked questions about Adjuvance Technologies
Where is Adjuvance Technologies headquartered?
Adjuvance Technologies Inc. is headquartered in Lincoln, Nebraska, United States.
What does Adjuvance Technologies do?
Adjuvance Technologies Inc. is a biotechnology company.
Similar companies
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
- Vaxcyte, Inc.San Carlos, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.